Revvity | PKI - Loan Capital



Revvity reported $3.21B in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Adcock Ingram Holdings ZAR 220.08M 18M Dec/2024
Agilent USD 3.35B 1000K Jul/2025
Align Technology USD 0 0 Dec/2024
Bio Techne USD 346M 16M Jun/2025
Bio-Rad Laboratories USD 1.2B 400K Jun/2025
Bruker USD 2.38B 303.5M Jun/2025
Celltrion KRW 114.04B 8.35B Mar/2025
Charles River Laboratories USD 2.33B 178.38M Jun/2025
Cspc Pharmaceutical CNY 56.14M 10.18M Dec/2024
Danaher USD 16.85B 877M Jun/2025
Dentsply International USD 2.22B 625M Jun/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd 20M 0 Mar/2025
Edwards Lifesciences USD 597.8M 100K Mar/2025
Exact Sciences USD 2.32B 9.48M Jun/2025
Hologic USD 2.51B 37.5M Jun/2025
Illumina USD 1.49B 1000K Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 14.18B 1.07B Jun/2025
Kangmei Pharma CNY 84.24M 3.67M Jun/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Laboratorios Farma EUR 101.36M 20.86M Jun/2025
Laboratory Of America USD 5.14B 425.8M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.76M 150K Dec/2024
Mettler Toledo International USD 2.12B 232.49M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 52.8M 9.51M Jun/2025
Pharma Mar EUR 37.57M 2.66M Jun/2025
Qiagen NV USD 884.85M 467.8M Jun/2025
Quest Diagnostics USD 5.17B 689M Jun/2025
Quidel USD 2.07B 33.8M Jun/2025
Repligen USD 533.72M 4.12M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
Sartorius EUR 4.09B 112.3M Jun/2025
Sino Biopharmaceutical CNY 2.08B 915.48M Dec/2024
Thermo Fisher Scientific USD 33.02B 1.64B Jun/2025
Tilray USD 316.63M 15.02M Nov/2024
Waters USD 1.2B 159.76M Jun/2025
Zz Pientze Pharmaceu 196.31M 8.23M Jun/2025